KRAS mutations impact clinical outcome in metastatic non-small cell lung cancer

Ella A. Eklund, Clotilde Wiel, Henrik Fagman, Levent M. Akyürek, Sukanya Raghavan, Jan Nyman, Andreas Hallqvist, Volkan I. Sayin
doi: https://doi.org/10.1101/2021.11.27.21266822

Article usage

Article usage: November 2021 to January 2025

AbstractFullPdf
Nov 2021230137
Dec 202136512105
Jan 2022852332
Feb 20222091465
Mar 20221403319
Apr 20221152430
May 2022803517
Jun 2022822619
Jul 2022712514
Aug 2022541911
Sep 2022523619
Oct 2022611813
Nov 202234143
Dec 2022342516
Jan 202326911
Feb 202325227
Mar 2023312413
Apr 202334165
May 202315197
Jun 20239144
Jul 202314153
Aug 202319207
Sep 202328217
Oct 202315224
Nov 202325248
Dec 20231433
Jan 202415179
Feb 202423139
Mar 202422159
Apr 2024172013
May 202416148
Jun 20242297
Jul 2024121010
Aug 2024231213
Sep 2024231110
Oct 202410126
Nov 20241359
Dec 202412410
Jan 2025222
Back to top
Posted February 14, 2022.
Download PDF

Supplementary Material

Data/Code
Email
KRAS mutations impact clinical outcome in metastatic non-small cell lung cancer
Ella A. Eklund, Clotilde Wiel, Henrik Fagman, Levent M. Akyürek, Sukanya Raghavan, Jan Nyman, Andreas Hallqvist, Volkan I. Sayin
medRxiv 2021.11.27.21266822; doi: https://doi.org/10.1101/2021.11.27.21266822
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area